Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
The aim of this study was to describe the type of risk-reducing gynaecologic surgery (RRGS) and the extent of pathological evaluation being undertaken for Australasian women at high familial risk of pelvic serous cancer. Surgical and pathology reports were reviewed for women with BRCA1/BRCA2 mutatio...
Main Authors: | Kiely, B. E., Friedlander, M. L., Milne, R. L., Stanhope, L., Russell, P., Jenkins, M. A., Weideman, P., McLachlan, S. A., Grant, P., Hopper, J. L., Phillips, K. A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Netherlands
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175342/ |
Similar Items
-
Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
by: Phillips, KA, et al.
Published: (2012) -
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
by: Phillips, Kelly-Anne, et al.
Published: (2016) -
BRCA and Early Events in the Development of Serous Ovarian Cancer
by: George, Sophia H. L., et al.
Published: (2014) -
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
by: Kotsopoulos, Joanne, et al.
Published: (2012) -
An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
by: Chenevix-Trench, Georgia, et al.
Published: (2007)